SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT financial statements, including revenue, expenses, profit, and loss

The total revenue of 600613 for the last quarter is 564.54 M CNY, and it's 13.22% higher compared to the previous quarter. The net income of Q1 24 is 23.94 M CNY.